232 related articles for article (PubMed ID: 23102701)
21. Epigenetic silencing of BCL6B inactivates p53 signaling and causes human hepatocellular carcinoma cell resist to 5-FU.
Li X; Yu J; Brock MV; Tao Q; Herman JG; Liang P; Guo M
Oncotarget; 2015 May; 6(13):11547-60. PubMed ID: 25909168
[TBL] [Abstract][Full Text] [Related]
22. Regulation of P53 stability in p53 mutated human and mouse hepatoma cells.
Hailfinger S; Jaworski M; Marx-Stoelting P; Wanke I; Schwarz M
Int J Cancer; 2007 Apr; 120(7):1459-64. PubMed ID: 17205518
[TBL] [Abstract][Full Text] [Related]
23. The DEAD-box RNA helicase DDX41 is a novel repressor of p21
Peters D; Radine C; Reese A; Budach W; Sohn D; Jänicke RU
J Biol Chem; 2017 May; 292(20):8331-8341. PubMed ID: 28348086
[TBL] [Abstract][Full Text] [Related]
24. Molecular Pathways Leading to Induction of Cell Death and Anti-Proliferative Properties by Tacrolimus and mTOR Inhibitors in Liver Cancer Cells.
Navarro-Villarán E; de la Cruz-Ojeda P; Contreras L; González R; Negrete M; Rodríguez-Hernández MA; Marín-Gómez LM; Álamo-Martínez JM; Calvo A; Gómez-Bravo MA; de la Cruz J; Padillo J; Muntané J
Cell Physiol Biochem; 2020 May; 54(3):457-473. PubMed ID: 32369692
[TBL] [Abstract][Full Text] [Related]
25. Negative regulation of transcription factor FoxM1 by p53 enhances oxaliplatin-induced senescence in hepatocellular carcinoma.
Qu K; Xu X; Liu C; Wu Q; Wei J; Meng F; Zhou L; Wang Z; Lei L; Liu P
Cancer Lett; 2013 Apr; 331(1):105-14. PubMed ID: 23262037
[TBL] [Abstract][Full Text] [Related]
26. Growth arrest induced by C75, A fatty acid synthase inhibitor, was partially modulated by p38 MAPK but not by p53 in human hepatocellular carcinoma.
Gao Y; Lin LP; Zhu CH; Chen Y; Hou YT; Ding J
Cancer Biol Ther; 2006 Aug; 5(8):978-85. PubMed ID: 16855382
[TBL] [Abstract][Full Text] [Related]
27. Suppression of TG-interacting factor sensitizes arsenic trioxide-induced apoptosis in human hepatocellular carcinoma cells.
Liu ZM; Tseng JT; Hong DY; Huang HS
Biochem J; 2011 Sep; 438(2):349-58. PubMed ID: 21649584
[TBL] [Abstract][Full Text] [Related]
28. Pro-apoptotic and anticancer properties of Thapring - A Tibetan herbal formulation.
Choedon T; Dolma D; Kumar V
J Ethnopharmacol; 2011 Sep; 137(1):320-6. PubMed ID: 21658439
[TBL] [Abstract][Full Text] [Related]
29. Rbm24, an RNA-binding protein and a target of p53, regulates p21 expression via mRNA stability.
Jiang Y; Zhang M; Qian Y; Xu E; Zhang J; Chen X
J Biol Chem; 2014 Feb; 289(6):3164-75. PubMed ID: 24356969
[TBL] [Abstract][Full Text] [Related]
30. Transcription factor KLF9 suppresses the growth of hepatocellular carcinoma cells in vivo and positively regulates p53 expression.
Sun J; Wang B; Liu Y; Zhang L; Ma A; Yang Z; Ji Y; Liu Y
Cancer Lett; 2014 Dec; 355(1):25-33. PubMed ID: 25242357
[TBL] [Abstract][Full Text] [Related]
31. Induction of p21 and p27 expression by amino acid deprivation of HepG2 human hepatoma cells involves mRNA stabilization.
Leung-Pineda V; Pan Y; Chen H; Kilberg MS
Biochem J; 2004 Apr; 379(Pt 1):79-88. PubMed ID: 14715082
[TBL] [Abstract][Full Text] [Related]
32. IGFBP-rP1 induces p21 expression through a p53-independent pathway, leading to cellular senescence of MCF-7 breast cancer cells.
Zuo S; Liu C; Wang J; Wang F; Xu W; Cui S; Yuan L; Chen X; Fan W; Cui M; Song G
J Cancer Res Clin Oncol; 2012 Jun; 138(6):1045-55. PubMed ID: 22392074
[TBL] [Abstract][Full Text] [Related]
33. ING1 represses transcription by direct DNA binding and through effects on p53.
Kataoka H; Bonnefin P; Vieyra D; Feng X; Hara Y; Miura Y; Joh T; Nakabayashi H; Vaziri H; Harris CC; Riabowol K
Cancer Res; 2003 Sep; 63(18):5785-92. PubMed ID: 14522900
[TBL] [Abstract][Full Text] [Related]
34. p21/WAF1, p53 and PCNA expression and p53 mutation status in hepatocellular carcinoma.
Qin LF; Ng IO; Fan ST; Ng M
Int J Cancer; 1998 Aug; 79(4):424-8. PubMed ID: 9699537
[TBL] [Abstract][Full Text] [Related]
35. p73 expression is regulated by RNPC1, a target of the p53 family, via mRNA stability.
Yan W; Zhang J; Zhang Y; Jung YS; Chen X
Mol Cell Biol; 2012 Jul; 32(13):2336-48. PubMed ID: 22508983
[TBL] [Abstract][Full Text] [Related]
36. Hepatitis B virus core promoter mutations contribute to hepatocarcinogenesis by deregulating SKP2 and its target, p21.
Huang Y; Tong S; Tai AW; Hussain M; Lok AS
Gastroenterology; 2011 Oct; 141(4):1412-21, 1421.e1-5. PubMed ID: 21704589
[TBL] [Abstract][Full Text] [Related]
37. Histone deacetylases activate hepatocyte growth factor signaling by repressing microRNA-449 in hepatocellular carcinoma cells.
Buurman R; Gürlevik E; Schäffer V; Eilers M; Sandbothe M; Kreipe H; Wilkens L; Schlegelberger B; Kühnel F; Skawran B
Gastroenterology; 2012 Sep; 143(3):811-820.e15. PubMed ID: 22641068
[TBL] [Abstract][Full Text] [Related]
38. Hemistepsin A Inhibits Cell Proliferation and Induces G0/G1-Phase Arrest, Cellular Senescence and Apoptosis Via the AMPK and p53/p21 Signals in Human Hepatocellular Carcinoma.
Baek SY; Hwang UW; Suk HY; Kim YW
Biomolecules; 2020 May; 10(5):. PubMed ID: 32375410
[TBL] [Abstract][Full Text] [Related]
39. Disruption of a regulatory loop between DUSP1 and p53 contributes to hepatocellular carcinoma development and progression.
Hao PP; Li H; Lee MJ; Wang YP; Kim JH; Yu GR; Lee SY; Leem SH; Jang KY; Kim DG
J Hepatol; 2015 Jun; 62(6):1278-86. PubMed ID: 25617504
[TBL] [Abstract][Full Text] [Related]
40. Reduced p21(WAF1/CIP1) protein expression is predominantly related to altered p53 in hepatocellular carcinomas.
Shi YZ; Hui AM; Takayama T; Li X; Cui X; Makuuchi M
Br J Cancer; 2000 Jul; 83(1):50-5. PubMed ID: 10883667
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
